English | Español
Patient Daily | Mar 17, 2026

Study finds treatment gap for young ADHD patients with substance use disorders
Patient Daily | Mar 17, 2026

AI model aims to improve fairness and speed in disaster aid delivery
Patient Daily | Mar 17, 2026

Solid Biosciences reports new data for Duchenne gene therapy in Phase 1/2 trial
Patient Daily | Mar 17, 2026

Evaluate projects rare disease drug sales to surpass $400 billion by 2032
Patient Daily | Mar 17, 2026

Biotechs report regulatory challenges and key catalysts in fourth quarter earnings
Patient Daily | Mar 17, 2026

FDA transparency questioned after official’s anonymous comments on Huntington’s therapy
Patient Daily | Mar 17, 2026

Penn experts propose a tobacco playbook for food policy
Patient Daily | Mar 17, 2026

Preclinical study suggests new cream may slow or prevent some common skin cancers

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial